CalAIM 1115 Demonstration Evaluations
Return to CalAIM 1115 Demonstration and 1915b Waiver HomepageAs required by the CalAIM 1115 Demonstration's Special Terms and Conditions, the State must submit evaluation reports to the Centers for Medicare and Medicaid Services (CMS) to determine and analyze the impacts of several demonstration programs over the course of the demonstration period. If you have any questions or concerns, please contact
1115Waiver@dhcs.ca.gov.
On June 27, 2022, DHCS submitted the
Draft Evaluation Design for Providing Access and Transforming Health (PATH) Initiative, Global Payment Program (GPP), and Dually Eligible Beneficiary Satisfaction in the Medi-Cal Matching Process.
On December 5, 2022, DHCS received CMS comments on the Draft Evaluation Design. The due date for the PATH/GPP/Duals Evaluation Design has been formally extended by CMS to January 25, 2024.
On February 7, 2024, DHCS submitted a revised Draft Evaluation Design and letter containing Responses to CMS's December 5, 2022 Questions for the PATH/GPP/Duals and the Reentry Demonstration.
COVID-19 Public Health Emergency - Managed Care Risk Mitigation Strategies
Drug Medi-Cal Organized Delivery System (DMC-ODS)
Additional information about the DMC-ODS Evaluation is available on the UCLA ISAP webpage.
Covid-19 Public Health Emergency Amendment – Attachment FF Evaluation Design
